Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products.
On April 18, 2025 Daewoong announced that it has filed for marketing authorization for Enblo in six Latin American countries, including Costa Rica, Honduras, the Dominican Republic, Panama, El Salvador, and Guatemala, as well as in Russia.